ANGELI MAYADEV: Open Payments
NPI 1891804530 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,260 in 14 payments from 6 companies in 2025. Trend: 2023 $12,196 · 2024 $1,980 · 2025 $7,260
Speaker / faculty: $6,038Consulting: $900Food & beverage: $281Travel & lodging: $41
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $6,127 |
| F. Hoffmann-La Roche AG | 1 | $900 |
| JAZZ PHARMACEUTICALS INC. | 1 | $114 |
| Ipsen Biopharmaceuticals, Inc | 2 | $62 |
| TG Therapeutics, Inc. | 2 | $41 |
| Genentech, Inc. | 1 | $16 |
Products named: BOTOX, EPIDIOLEX, Dysport, BRIUMVI, Ocrevus.
Industry payments across WA — which companies pay providers there.
